Stimulation of local antibody production: parenteral or mucosal vaccination?

被引：51

作者：

Bouvet, JP ^{[1
]}

Decroix, N ^{[1
]}

Pamonsinlapatham, P ^{[1
]}

机构：

[1] Hop Broussais, INSERM, UR430, Immunopathol Unit, F-75014 Paris, France

来源：

TRENDS IN IMMUNOLOGY | 2002年 / 23卷 / 04期

关键词：

D O I：

10.1016/S1471-4906(02)02186-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mucosal vaccines aim to prevent the penetration of pathogens, including HIV, into the body. Their cost can be low compared with curative therapies and thus, they are well suited to the fight against pandemic diseases in developing countries. Efficacy has been demonstrated for the oral poliovirus vaccine, but only very few other vaccines administered by the mucosal route are available commercially at present. Tremendous research efforts have now improved significantly the classical approach of these vaccines, and alternative methods of immunization, based on new concepts of mucosal immunity, are being developed.

引用

页码：209 / 213

页数：5

共 52 条

[21] The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity [J].

Enioutina, EY ;

Visic, D ;

Daynes, RA .

VACCINE, 2000, 18 (24) :2753-2767

[22] The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant [J].

Enioutina, EY ;

Visic, D ;

McGee, ZA ;

Daynes, RA .

VACCINE, 1999, 17 (23-24) :3050-3064

[23] DNA VACCINES - PROTECTIVE IMMUNIZATIONS BY PARENTERAL, MUCOSAL, AND GENE-GUN INOCULATIONS [J].

FYNAN, EF ;

WEBSTER, RG ;

FULLER, DH ;

HAYNES, JR ;

SANTORO, JC ;

ROBINSON, HL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11478-11482

[24] Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract [J].

Gallichan, WS ;

Woolstencroft, RN ;

Guarasci, T ;

McCluskie, MJ ;

Davis, HL ;

Rosenthal, KL .

JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3451-3457

[25]

Glenn GM, 1998, J IMMUNOL, V161, P3211

[26] Transcutaneous immunization: A human vaccine delivery strategy using a patch [J].

Glenn, GM ;

Taylor, DN ;

Li, XR ;

Frankel, S ;

Montemarano, A ;

Alving, CR .

NATURE MEDICINE, 2000, 6 (12) :1403-1406

[27] Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract [J].

Gockel, CM ;

Bao, SS ;

Beagley, KW .

MOLECULAR IMMUNOLOGY, 2000, 37 (09) :537-544

[28]

GUILBERT B, 1982, J IMMUNOL, V128, P2779

[29] Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine [J].

Jertborn, M ;

Svennerholm, AM ;

Holmgren, J .

VACCINE, 1996, 14 (15) :1459-1465

[30] Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: Critical evaluation of experimental evidence [J].

Kilian, M ;

Reinholdt, J ;

Lomholt, H ;

Poulsen, K ;

Frandsen, EVG .

APMIS, 1996, 104 (05) :321-338

← 1 2 3 4 5 6 →